GLP-1 weight-loss drugs for overweight cats tested by startups

Startups are testing GLP-1 drugs — similar to Ozempic — on overweight cats as pet obesity becomes a growing concern among owners. At the same time, major pet-food companies are launching longevity-focused product lines to capitalise on rising spending on animal health. The veterinary weight-loss drug market could expand significantly in coming years.